• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Oncology Technology Solutions, Services Impacting Patients and Providers

Thriving in a Value-Based Care Environment: Impacting Outcome-to-Cost Ratio

by Jerry Carlson, Product Support Manager, BG DI BU IC Sales, Dunlee 10/14/2020 Leave a Comment

Thriving in a value-based care environment: impacting the outcome-to-cost ratio

As the COVID-19 pandemic creates surges in acute care, many imaging departments are experiencing a decrease in volume, due to patients deferring or canceling non-urgent appointments and surgeries. The impact of this makes it painfully obvious that -- because imaging departments rely on a fee-for-service model – when the volume is down, finances suffer. As an aspect of healthcare that has historically been hyper-focused on volume, adoption of a value-based care approach in radiology has evolved
Read More

Syapse Appoints David Pomerantz as Chief Commercial Officer

by Jasmine Pennic 09/03/2020 Leave a Comment

Syapse Appoints David Pomerantz as Chief Commercial Officer

Syapse, a real-world evidence company accelerating the delivery of precision medicine through the Syapse Learning Health Network™, today announced the appointment of David Pomerantz as Chief Commercial Officer. In his new role as Chief Commercial Officer, Pomerantz will lead the future direction of Syapse’s commercial endeavors and expand its life sciences partnerships across the Syapse Learning Network. Pomerantz Bio/Background Mr. Pomerantz brings more than 25 years of account
Read More

Biofourmis Lands $100M to Expand AI-Powered Digital Therapeutics Platform

by Fred Pennic 09/03/2020 Leave a Comment

Biofourmis Lands $100M to Expand AI-Powered Digital Therapeutics Platform

What You Should Know: - Boston-based digital therapeutics leader Biofourmis just closed a $100 million Series C funding round led by SoftBank, bringing its total funding to $145M.   - Biofourmis will be using the funding to develop, validate and commercialize several released and unreleased digital therapeutics solutions across cardiology, oncology, respiratory, and pain, with a focus on the United States and key Asian markets, including Asia Pacific, China, and
Read More

CancerIQ Raises $5M to Expand Genetic Cancer Risk Assessment Platform

by Fred Pennic 08/14/2020 Leave a Comment

CancerIQ Raises $5M to Expand Genetic Cancer Risk Assessment Platform

What You Should Know: - CancerIQ raises $5M in Series A funding led by HealthXVentures to accelerate the growth of its genetic cancer risk assessment platform to identify and manage patients at high risk of cancer. - CancerIQ’s technology enables hospitals to use genomics to personalize the prevention and early detection of cancer. - Two new hires recently joined CancerIQ’s newly formed Integrated Products team from Epic, with the goal of advancing CancerIQ’s integration with leading
Read More

FDA, Syapse Expand Research to Generate Real-World Data Related to COVID-19 and Cancer

by Jasmine Pennic 08/11/2020 Leave a Comment

FDA, Syapse Expand Research to Generate Real-World Data Related to COVID-19 and Cancer

What You Should Know: The FDA and Syapse announce research collaboration expansion to address urgent public health challenges including supporting FDA’s goal of rapid understanding of COVID-19. As part of the research, Syapse is partnering with FDA’s Oncology Center of Excellence to investigate methods to derive RWD from multiple sources including electronic health records, registries and molecular data Syapse, a real-world evidence company accelerating the delivery of precision
Read More

M&A Analysis: 3 Benefits of Siemens Healthineers’ $16.4B Acquisition of Varian Medical

by Steve Holloway, Director at Signify Research 08/07/2020 Leave a Comment

M&A Analysis: 3 Benefits of Siemens Healthineers $16.4B Acquisition of Varian Medical

What You Should Know: - Siemens Healthineers and Varian Medical announce a $16.4B deal in an all-cash transaction on 2nd August 2020. - Deal expected to close in 1H 2021. - Varian Medical will maintain its brand name and operate “independently” - Siemens AG will drop holding in Siemens Healthineers from 85% to 72% as part of the transaction. News of the deal between Siemens Healthineers and Varian Medical will have caught many industry onlookers off guard on Sunday evening.
Read More

COVID-19 Has Permanently Shifted Patient Behavior Towards Virtual Care

by Jasmine Pennic 07/10/2020 Leave a Comment

Report: How COVID-19 Has Permanently Changed Patient Behavior Towards Virtual Care

What You Should Know: - The COVID-19 crisis has significantly impacted the patient care paradigm, and the ripple effects have altered patient behaviors and expectations, requiring a significant change in how life sciences companies engage with and support patients - Accenture surveyed 2700 patients about changes in care during COVID-19 and found a major shift to virtual care, which patients embraced. - Virtual care is here to stay and can be an integral part of the patient experience
Read More

Brainlab Acquires Medical Video Game Innovator Level Ex

by Fred Pennic 06/29/2020 Leave a Comment

Brainlab Acquires Medical Video Game Innovator Level Ex

What You Should Know: - Brainlab, a digital medical technology company based in Munich, Germany has acquired Level Ex, a digital health startup creating medical video games designed to advance the clinical skills of physicians and surgeons. - The acquisition will accelerate product development, allow Level Ex to enter new clinical areas faster, and expand its footprint in global markets, benefitting more medical professionals across a wider-range of specialties and cases. - Level Ex
Read More

MD Anderson, Philips Partner on Personalized Oncology Treatments, Clinical Trial Matching

by Fred Pennic 06/16/2020 Leave a Comment

Philips and MD Anderson collaborate to facilitate personalized oncology treatments and clinical trial matching based on genomic markers

What You Should Know: - Philips and MD Anderson collaborate to facilitate personalized oncology treatments and clinical trial matching based on genomic markers. - Philips connects oncologists and pathologists around the world to MD Anderson’s Precision Oncology Decision Support (PODS) system of actionable clinical information Philips and The University of Texas MD Anderson Cancer Center today announced a collaboration to provide oncologists with evidence-based therapy and clinical
Read More

Backed by Northwell, Conversa Health Raises $12M for AI-Powered Chatbots

by Fred Pennic 06/11/2020 Leave a Comment

Backed by Northwell, Conversa Health Raises $12M for AI-Powered Chatbots

What You Should Know: - Conversa Health raises $12 million in Series B funding round to expand its AI-powered chatbots enabling health systems, payers and pharmaceutical companies to engage patients and collect patient-generated health data and patient-reported outcomes. - Conversa plans to use the funding to scale its virtual care and communication platform—97 percent of patients who have used its chatbots say they can better manage their care with Conversa.  - Murray Brozinsky
Read More

  • Previous Page
  • Go to page 1
  • Interim pages omitted …
  • Go to page 18
  • Go to page 19
  • Go to page 20
  • Go to page 21
  • Go to page 22
  • Interim pages omitted …
  • Go to page 29
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Virta Health CEO: GLP-1s Didn’t Kill Weight Watchers, Its Broken Model Did

Most-Read

Moving Beyond EHRs: What Lies Ahead for Healthcare Digitization?

AI Agents vs. Chatbots: Understanding Agentic AI’s Role in Healthcare

AI Breakthrough Reveals 2025 AI Breakthrough Award Winners

AI Breakthrough Reveals 2025 AI Breakthrough Award Winners

Healthcare's Big Blind Spot: The Measurement Crisis in Inpatient Psychiatry

Healthcare’s Big Blind Spot: The Measurement Crisis in Inpatient Psychiatry

Lessons Learned from The Change Healthcare Cyberattack, One Year Later

Lessons Learned from The Change Healthcare Cyberattack, One Year Later

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Soars in NASDAQ Debut, Signaling Digital Health IPO Rebound

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |